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Abstract Central nervous system regeneration after injury
can occur in the form of remyelination, the reinstatement of
myelin around axons which restores axon health and function.
However, remyelination often fails in chronic neurological
diseases, such as progressive multiple sclerosis. The lack of
currently approved pro-remyelination therapies highlights the
need to elucidate the cellular and molecular mechanisms un-
derpinning this regenerative process. Whereas some T lym-
phocyte subsets such as Th1 and Th17 are implicated in in-
ducing myelin injury, a recent study by Dombrowski et al.
reveals a novel role for regulatory T cells (Tregs) in directly
driving remyelination, independent of immunomodulation
(Nat Neurosci doi:10.1038/nn.4528 2017)(Dombrowski
et al., 2017). This study is summarized in this Bits and Bytes.
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Regeneration can occur efficiently in the central nervous sys-
tem (CNS) in the form of remyelination, whereby new myelin
is ensheathed around axons to reinstate trophic/ metabolic
support and insulation for electrical impulse conduction.
This process requires oligodendrocyte progenitor cells
(OPCs) to migrate to areas of injury, proliferate, and differen-
tiate into myelin-producing oligodendrocytes. Remyelination
is limited or fails altogether in various neurological disorders,
most prominently in progressive multiple sclerosis (MS),
leading to axon dysfunction or loss. Although it is recognized
that this failure largely reflects impaired oligodendrocyte dif-
ferentiation (Kuhlmann et al., 2008), the mechanisms under-
pinning successful remyelination are still not fully understood.
This highlights the importance of identifying the cells and
molecules driving remyelination in order to develop effective
regenerative therapies.
While it is now recognized that the innate immune system
(i.e. macrophages) supports remyelination (Davies andMiron,
2016; Lloyd and Miron, 2016), the adaptive immune system
(e.g. T lymphocytes) has historically been considered delete-
rious for oligodendrocytes/ remyelination. For instance, pro-
inflammatory Th1 and Th17 T cells have direct cytotoxic ef-
fects on human OPCs in vitro (Moore et al., 2015) and reduce
remyelination in vivo (Baxi et al., 2015). However, the im-
pairment of remyelination following depletion of total CD4+
or CD8+ T cell populations (Bieber et al., 2003) points to the
existence of a pro-regenerative T cell subset. Consistent with
this postulate, a T cell presence in MS lesions is concurrent
with ongoing remyelination. Indeed, a recent study by
Dombrowski and Fitzgerald and colleagues (Dombrowski
et al., 2017) revealed a novel pro-regenerative role for regula-
tory Tcells (Tregs), demonstrating that these cells directly stim-
ulate remyelination independent of immunomodulation.
Using a focal model of toxin-induced demyelination in the
mouse spinal cord, where the temporal distinction between
myelin damage and remyelination allows investigations of
the regenerative process in isolation, Tregs (CD3+ CD4+
Foxp3+) were detected in lesions at the time of oligodendro-
cyte differentiation and remyelination initiation (Dombrowski
et al., 2017). These cells were found to be required for
remyelination, as their specific depletion in a Foxp3-driven
diphtheria toxin receptor model (Foxp3-DTR) led to reduced
numbers of oligodendrocytes and remyelinated axons
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(Dombrowski et al., 2017). This was rescued by supplemen-
tation with exogenous wildtype Tregs. The effects of Treg de-
pletion were mirrored in a distinct demyelination model
(Dombrowski et al., 2017), whereby select oligodendrocytes
in the brain are killed via copper chelation by the cuprizone
toxin, confirming that the role of Tregs in remyelination is not
dependent on the mode of demyelination nor is it restricted to
the spinal cord.
Treg depletion in both models did not alter numbers of total
oligodendrocyte lineage cells nor proliferating OPCs, suggest-
ing effects of Tregs on the differentiation of OPCs into mature
myelinating oligodendrocytes. Indeed, exposing brain ex-
plants to Tregs or their conditioned media enhanced oligoden-
drocyte differentiation, myelination, and remyelination, in
comparison to non-polarized CD4+ T cells (Dombrowski
et al . , 2017). These effects were independent of
immunomodulation of i) the peripheral immune system, as
explants are devoid of a circulation, and ii) microglia and
astrocytes, as effects were still observed when their inflamma-
tory response to dissection had subsided (Dombrowski et al.,
2017). A direct effect of Tregs on OPCs was confirmed in vitro,
where Treg conditioned media enhanced the differentiation of
isolated OPCs and accelerated myelination in OPC-neuronal
co-cultures (Dombrowski et al., 2017). Proteomic profiling of
Treg conditioned media was carried out to identify pro-
remyelination factors, and identified high expression of the
growth regulator CCN3 (Dombrowski et al., 2017). This fac-
tor has previously been shown to be involved in tooth regen-
eration (Wang et al., 2014), but never shown to be expressed
either by T cells or during CNS regeneration. CCN3 was
found to be a critical component of the beneficial effects of
Treg conditioned media, as use of a blocking antibody or spe-
cific depletion from the conditioned media abolished the pro-
differentiation and pro-myelination effects (Dombrowski
et al., 2017). Importantly, Treg-derived CCN3 was sufficient
to support these responses (Dombrowski et al., 2017).
Altogether, these data demonstrate that Tregs are direct
drivers of oligodendrocyte differentiation and remyelination,
thereby revealing a novel regenerative function for Tregs be-
yond immunomodulation. Considering this study, one must
now acknowledge that the adaptive immune system is not
solely involved in damage induction and modulation of in-
flammation, but is also a critical component of the regenera-
tive process that follows. A recent study demonstrated that
MS patient-derived CD4+ T cells injected into demyelinated
mouse CNS show high variability in their ability to support
remyelination (El Behi et al., 2017), leading to the tantalizing
possibility that the inter-patient variation in remyelination
efficiency in MS might reflect diverging capacity of Tregs to
stimulate remyelination. Overall, these studies support that
further investigations into the pro-remyelination function of
Tregs and CCN3 in MS are warranted for development of nov-
el regenerative therapies.
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